Demystified ...: Monoclonal antibodies
- 1 June 2000
- journal article
- review article
- Published by BMJ in Molecular Pathology
- Vol. 53 (3) , 111-117
- https://doi.org/10.1136/mp.53.3.111
Abstract
Monoclonal antibodies are essential tools for many molecular immunology investigations. In particular, when used in combination with techniques such as epitope mapping and molecular modelling, monoclonal antibodies enable the antigenic profiling and visualisation of macromolecular surfaces. In addition, monoclonal antibodies have become key components in a vast array of clinical laboratory diagnostic tests. Their wide application in detecting and identifying serum analytes, cell markers, and pathogenic agents has largely arisen through the exquisite specificity of these unique reagents. Furthermore, the continuous culture of hybridoma cells that produce these antibodies offers the potential of an unlimited supply of reagent. In essence, when compared with the rather limited supply of polyclonal antibody reagents, the feature of a continuous supply enables the standardisation of both the reagent and the assay technique. Clearly, polyclonal and monoclonal antibodies have their advantages and disadvantages in terms of generation, cost, and overall applications. Ultimately, monoclonal antibodies are only produced when necessary because their production is time consuming and frustrating, although greatly rewarding (at least most of the time!). This is especially apparent when a monoclonal antibody can be applied successfully in a routine pathology laboratory or can aid in the clinical diagnosis and treatment of patients. In this article, the generation and application of monoclonal antibodies are demystified to enable greater understanding and hopefully formulate novel ideas for clinicians and scientists alike.Keywords
This publication has 45 references indexed in Scilit:
- The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapySeminars in Cancer Biology, 1999
- Down-Regulation of p27 Is Associated with Development of Colorectal Adenocarcinoma MetastasesThe American Journal of Pathology, 1998
- High level expression of p27 kip1 and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27 kip1 and degree of malignancy in human breast and colorectal cancersProceedings of the National Academy of Sciences, 1997
- Fine specificity of autoantibodies to La/SSB: epitope mapping, and characterizationClinical and Experimental Immunology, 1997
- Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patientsNature Medicine, 1997
- Inhibition of erbB-2-Positive Breast Cancer Cell Growth by erbB-2 Antisense OligonucleotidesAntisense and Nucleic Acid Drug Development, 1996
- Utilization of activated U937 monocytic cells as a model to evaluate biocompatibility and biodegradation of synthetic calcium phosphateBiomaterials, 1995
- The prognostic value of c-erbB2 in primary breast carcinomas: A study on 942 casesBreast Cancer Research and Treatment, 1995
- Asasy restriction profiles of three monoclonal antibodies recognizing the G3m(u) allotype: Development of an allotype specific assayJournal of Immunological Methods, 1991
- Evaluation of Monoclonal Antibodies with Putative Specificity for Human IgG AllotypesVox Sanguinis, 1990